15-82659567-G-A

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting

The NM_001278512.2(AP3B2):​c.3299C>T​(p.Thr1100Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000196 in 1,613,720 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1100S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000092 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00021 ( 0 hom. )

Consequence

AP3B2
NM_001278512.2 missense

Scores

9
10

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 5.54
Variant links:
Genes affected
AP3B2 (HGNC:567): (adaptor related protein complex 3 subunit beta 2) Adaptor protein complex 3 (AP-3 complex) is a heterotrimeric protein complex involved in the formation of clathrin-coated synaptic vesicles. The protein encoded by this gene represents the beta subunit of the neuron-specific AP-3 complex and was first identified as the target antigen in human paraneoplastic neurologic disorders. The encoded subunit binds clathrin and is phosphorylated by a casein kinase-like protein, which mediates synaptic vesicle coat assembly. Defects in this gene are a cause of early-onset epileptic encephalopathy. [provided by RefSeq, Feb 2017]
CPEB1-AS1 (HGNC:27523): (CPEB1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.21693698).
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.000207 (302/1461554) while in subpopulation NFE AF= 0.000255 (283/1111828). AF 95% confidence interval is 0.00023. There are 0 homozygotes in gnomad4_exome. There are 145 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
AP3B2NM_001278512.2 linkuse as main transcriptc.3299C>T p.Thr1100Ile missense_variant 27/27 ENST00000535359.6
CPEB1-AS1NR_046096.1 linkuse as main transcriptn.1328+9421G>A intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
AP3B2ENST00000535359.6 linkuse as main transcriptc.3299C>T p.Thr1100Ile missense_variant 27/271 NM_001278512.2 Q13367-4
CPEB1-AS1ENST00000560650.1 linkuse as main transcriptn.1328+9421G>A intron_variant, non_coding_transcript_variant 1

Frequencies

GnomAD3 genomes
AF:
0.0000920
AC:
14
AN:
152166
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000642
AC:
16
AN:
249130
Hom.:
0
AF XY:
0.0000666
AC XY:
9
AN XY:
135158
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000186
Gnomad NFE exome
AF:
0.000106
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000207
AC:
302
AN:
1461554
Hom.:
0
Cov.:
31
AF XY:
0.000199
AC XY:
145
AN XY:
727072
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000225
Gnomad4 NFE exome
AF:
0.000255
Gnomad4 OTH exome
AF:
0.0000994
GnomAD4 genome
AF:
0.0000920
AC:
14
AN:
152166
Hom.:
0
Cov.:
32
AF XY:
0.000121
AC XY:
9
AN XY:
74326
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000942
Gnomad4 NFE
AF:
0.000191
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000111
Hom.:
0
Bravo
AF:
0.0000756
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000119
AC:
1
ExAC
AF:
0.0000330
AC:
4
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJul 06, 2023Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpAug 09, 2022This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 1081 of the AP3B2 protein (p.Thr1081Ile). This variant is present in population databases (rs201428733, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with AP3B2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1394935). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 04, 2022The c.3242C>T (p.T1081I) alteration is located in exon 26 (coding exon 26) of the AP3B2 gene. This alteration results from a C to T substitution at nucleotide position 3242, causing the threonine (T) at amino acid position 1081 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.54
.;D;D;.;.
Eigen
Benign
-0.14
Eigen_PC
Benign
-0.13
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.77
T;.;T;T;T
M_CAP
Uncertain
0.089
D
MetaRNN
Benign
0.22
T;T;T;T;T
MetaSVM
Benign
-0.76
T
MutationAssessor
Uncertain
2.1
.;M;M;.;.
MutationTaster
Benign
0.94
D;D;D
PrimateAI
Uncertain
0.59
T
PROVEAN
Uncertain
-3.0
.;D;.;D;D
REVEL
Benign
0.11
Sift
Uncertain
0.0040
.;D;.;D;D
Sift4G
Uncertain
0.0030
.;D;D;D;D
Polyphen
0.0010
.;B;B;.;.
Vest4
0.22, 0.20, 0.32, 0.31
MVP
0.44
MPC
0.14
ClinPred
0.45
T
GERP RS
1.8
Varity_R
0.11
gMVP
0.23

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201428733; hg19: chr15-83328319; API